ReviewAnnals of hematology2024

Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review.

Mina Meseha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.